Contamination Genomics Protein 
XTalks
NOVEMBER 7, 2022
These tumor-derived entities are used to derive genomic and proteomic data. However, Dr. Bahassi reported that the selection of CTCs using this method is often not very efficient and the CTC population is usually highly contaminated with leukocytes. Detection of Genomic Alterations from cfDNA: Targeted, Non-Personalized Approaches.
Pharmaceutical Technology
APRIL 27, 2023
Genomic medicine development was ranked as the top industry trend for 2023 in a survey of 198 GlobalData Pharma clients and prospects conducted between October and November 2022. Every stage of development should result in a reproducible, safe drug product with no cross contamination from one batch to another. billion by 2028.
Expert insights. Personalized for you.
94 
Let's personalize your content